Physician profile
Jonathan M Blau
NPI 1396066619
$1,623.10
in general payments reported to CMS, 2019-2025
13 companies · $1,054 in 2025
The $1,054 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $60.36 · 2021: $89.01 · 2022: $87.64 · 2023: $48.88 · 2024: $284 · 2025: $1,054.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,386.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,386.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $391.43 | 2024-2025 | Comprehensive Shoulder System, Avitus Bone Harvester, Persona |
| Medtronic, INC. | $278.09 | 2025 | Intellis Adaptivestim |
| Stryker Corporation | $241.81 | 2021-2025 | Gamma, Mako |
| Uoc USA INC | $187.76 | 2025 | U-Star, Conformity, U2 |
| Saxum Surgical, INC. | $141.20 | 2024-2025 | |
| Convatec INC. | $79.05 | 2024-2025 | |
| Globus Medical, INC. | $66.77 | 2023-2024 | Troch Nail, Evo Retrograde |
| Ethicon US, LLC | $60.36 | 2020 | |
| Depuy Synthes Sales INC. | $54.01 | 2022-2024 | Monovisc, Orthovisc |
| Medical Device Business Services, INC. | $42.01 | 2021 | |
| Biotissue Holdings INC. | $38.64 | 2024 | |
| Bioventus LLC | $26.57 | 2024 | Exogen Ultrasound Bone Healing System |
| Curonix LLC | $15.40 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Blau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.